stella
beta
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma — Stella
Home
/
Neuroblastoma
/
View on ClinicalTrials.gov
Recruiting
Back to Neuroblastoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Children's Healthcare of Atlanta, Atlanta, Georgia